156 related articles for article (PubMed ID: 33226620)
1. Reprogramming of Fibroblasts to Human iPSCs by CRISPR Activators.
Weltner J; Trokovic R
Methods Mol Biol; 2021; 2239():175-198. PubMed ID: 33226620
[TBL] [Abstract][Full Text] [Related]
2. Generation of Human iPSCs by Episomal Reprogramming of Skin Fibroblasts and Peripheral Blood Mononuclear Cells.
Febbraro F; Chen M; Denham M
Methods Mol Biol; 2021; 2239():135-151. PubMed ID: 33226617
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming Human Fibroblasts to Induced Pluripotent Stem Cells Using the GFP-Marked Lentiviral Vectors in the Chemically Defined Medium.
Shao Z; Cevallos RR; Hu K
Methods Mol Biol; 2021; 2239():101-116. PubMed ID: 33226615
[TBL] [Abstract][Full Text] [Related]
4. Episomal Reprogramming of Human Peripheral Blood Mononuclear Cells into Pluripotency.
Wen W; Cheng T; Zhang XB
Methods Mol Biol; 2021; 2239():117-133. PubMed ID: 33226616
[TBL] [Abstract][Full Text] [Related]
5. Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency.
Yamakawa T; Sato Y; Matsumura Y; Kobayashi Y; Kawamura Y; Goshima N; Yamanaka S; Okita K
Stem Cells; 2016 Nov; 34(11):2661-2669. PubMed ID: 27335261
[TBL] [Abstract][Full Text] [Related]
6. Human pluripotent reprogramming with CRISPR activators.
Weltner J; Balboa D; Katayama S; Bespalov M; Krjutškov K; Jouhilahti EM; Trokovic R; Kere J; Otonkoski T
Nat Commun; 2018 Jul; 9(1):2643. PubMed ID: 29980666
[TBL] [Abstract][Full Text] [Related]
7. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
[TBL] [Abstract][Full Text] [Related]
8. Reprogramming Porcine Fibroblast to EPSCs.
Gao X; Ruan D; Liu P
Methods Mol Biol; 2021; 2239():199-211. PubMed ID: 33226621
[TBL] [Abstract][Full Text] [Related]
9. Evaluating Reprogramming Efficiency and Pluripotency of the Established Human iPSCS by Pluripotency Markers.
Cevallos RR; Hossain ME; Zhang R; Hu K
Methods Mol Biol; 2021; 2239():235-249. PubMed ID: 33226623
[TBL] [Abstract][Full Text] [Related]
10. RNA-Guided Activation of Pluripotency Genes in Human Fibroblasts.
Xiong K; Zhou Y; Blichfeld KA; Hyttel P; Bolund L; Freude KK; Luo Y
Cell Reprogram; 2017 Jun; 19(3):189-198. PubMed ID: 28557624
[TBL] [Abstract][Full Text] [Related]
11. Generation of Human iPSCs by Protein Reprogramming and Stimulation of TLR3 Signaling.
Liu C; Ameen M; Himmati S; Thomas D; Sayed N
Methods Mol Biol; 2021; 2239():153-162. PubMed ID: 33226618
[TBL] [Abstract][Full Text] [Related]
12. Conversion of partially reprogrammed cells to fully pluripotent stem cells is associated with further activation of stem cell maintenance- and gamete generation-related genes.
Kim JS; Choi HW; Choi S; Seo HG; Moon SH; Chung HM; Do JT
Stem Cells Dev; 2014 Nov; 23(21):2637-48. PubMed ID: 24892478
[TBL] [Abstract][Full Text] [Related]
13. Induced pluripotent stem cell generation from bovine somatic cells indicates unmet needs for pluripotency sustenance.
Pillai VV; Kei TG; Reddy SE; Das M; Abratte C; Cheong SH; Selvaraj V
Anim Sci J; 2019 Sep; 90(9):1149-1160. PubMed ID: 31322312
[TBL] [Abstract][Full Text] [Related]
14. Zinc finger nuclease-expressing baculoviral vectors mediate targeted genome integration of reprogramming factor genes to facilitate the generation of human induced pluripotent stem cells.
Phang RZ; Tay FC; Goh SL; Lau CH; Zhu H; Tan WK; Liang Q; Chen C; Du S; Li Z; Tay JC; Wu C; Zeng J; Fan W; Toh HC; Wang S
Stem Cells Transl Med; 2013 Dec; 2(12):935-45. PubMed ID: 24167318
[TBL] [Abstract][Full Text] [Related]
15. Integration-free induced pluripotent stem cells derived from a patient with autosomal recessive Alport syndrome (ARAS).
Kuebler B; Aran B; Miquel-Serra L; Muñoz Y; Ars E; Bullich G; Furlano M; Torra R; Marti M; Veiga A; Raya A
Stem Cell Res; 2017 Dec; 25():1-5. PubMed ID: 29246570
[TBL] [Abstract][Full Text] [Related]
16. Excluding Oct4 from Yamanaka Cocktail Unleashes the Developmental Potential of iPSCs.
Velychko S; Adachi K; Kim KP; Hou Y; MacCarthy CM; Wu G; Schöler HR
Cell Stem Cell; 2019 Dec; 25(6):737-753.e4. PubMed ID: 31708402
[TBL] [Abstract][Full Text] [Related]
17. Generation of human iPSCs from cells of fibroblastic and epithelial origin by means of the oriP/EBNA-1 episomal reprogramming system.
Drozd AM; Walczak MP; Piaskowski S; Stoczynska-Fidelus E; Rieske P; Grzela DP
Stem Cell Res Ther; 2015 Jun; 6(1):122. PubMed ID: 26088261
[TBL] [Abstract][Full Text] [Related]
18. Intermediate Standstill Clones Trapped in the Reprogramming of Human Fibroblasts to Induced Pluripotent Stem Cells.
Zhang L; Wang Y; Zhang Y; Wang L; Huang H
Cell Reprogram; 2020 Apr; 22(2):99-105. PubMed ID: 32182120
[TBL] [Abstract][Full Text] [Related]
19. Using low-risk factors to generate non-integrated human induced pluripotent stem cells from urine-derived cells.
Wang L; Chen Y; Guan C; Zhao Z; Li Q; Yang J; Mo J; Wang B; Wu W; Yang X; Song L; Li J
Stem Cell Res Ther; 2017 Nov; 8(1):245. PubMed ID: 29096702
[TBL] [Abstract][Full Text] [Related]
20. Zic3 enhances the generation of mouse induced pluripotent stem cells.
Declercq J; Sheshadri P; Verfaillie CM; Kumar A
Stem Cells Dev; 2013 Jul; 22(14):2017-25. PubMed ID: 23421367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
